Gastrointestinal Injury Clinical Trial
— BABSIPWAGIOfficial title:
Study on the Value of Digital Continuous Bowel Sound Monitoring in AGI of Critically Ill Patients With ICU
The incidence of gastrointestinal diseases is high in intensive care unit (intensive care unit,ICU). In critically ill patients, the intestinal tract is the "engine" of multiple organ dysfunction syndrome (Multiple organ dysfunction syndrome,MODS) and a component of multiple organ dysfunction syndrome, which is closely related to the poor prognosis of critically ill patients. In 2012, the abdominal working group of the European Association of critical Care Medicine (the European Society of Intensive Care Medicine,ESICM) put forward the concept of "acute gastrointestinal injury" (acute gastrointestinal injury,AGI), which was defined as gastrointestinal dysfunction caused by acute disease in critically ill patients. However, the grading system is complex and general, which does not reflect other gastrointestinal functions such as endocrine, immunity, barrier and so on, and lacks the support of objective laboratory results. When patients with acute gastrointestinal injury, gastrointestinal digestion and absorption, endocrine, immunity, barrier function are affected in varying degrees. The levels of indexes reflecting gastrointestinal digestion and absorption, endocrine and immunity were different among different AGI grades. The purpose of this study was to observe the characteristics of AGI bowel sounds in critically ill patients with ICU by digital continuous bowel sound monitoring, and to explore the clinical value of bowel sounds characteristics in AGI of critically ill patients combined with the changes of biomarkers of gastrointestinal injury.
Status | Recruiting |
Enrollment | 172 |
Est. completion date | September 25, 2022 |
Est. primary completion date | September 25, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Patients = 18 years old and = 80 years old. - The time of staying in ICU is expected to be more than 48 hours. - The patient or legal guardian or legal representative signs the informed consent form. Exclusion Criteria: - It is estimated that the hospitalization time of ICU is less than 24 hours, and the case data are incomplete. - Age > 80 years old; patients with chronic or primary gastrointestinal diseases (such as Crohn's disease, ulcerative colitis, gastrointestinal ulcer), short bowel syndrome, gastrointestinal surgery (history of partial or total gastrectomy), malignant tumor. - Pregnant or lactating women. - Patients with severe cardiovascular disease and hemodynamic instability may have cardiorespiratory arrest in a short period of time. - The patient himself or the agent refused to sign the informed consent form or participate in another clinical trial. - The researchers determined that other conditions in which the patient was not suitable for selection. |
Country | Name | City | State |
---|---|---|---|
China | First Affiliated Hospital of Xian JiaotongUniversity | Xi'an | Shaanxi |
Lead Sponsor | Collaborator |
---|---|
First Affiliated Hospital Xi'an Jiaotong University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes of 24-hour average intestinal sound rate | Times per minute | Days 1, 2, 3, 7 | |
Secondary | Changes of citrulline level | µmol/L | Days 1, 2, 3, 7 | |
Secondary | Changes of intestinal fatty acid binding protein level | ng/L | Days 1, 2, 3, 7 | |
Secondary | Changes of motilin level | ng/L | Days 1, 2, 3, 7 | |
Secondary | Changes of gastrin level | ng/L | Days 1, 2, 3, 7 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05226221 -
Gastrointestinal Emergency Surgery: Evaluation of Morbidity and Mortality
|
||
Completed |
NCT04111263 -
Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude
|
N/A | |
Completed |
NCT02127164 -
Vacuum Assisted Therapy in Emergent Contaminated Abdominal Surgeries
|
N/A | |
Completed |
NCT03198741 -
Mono- Versus Dual antiPlatelet Therapy During 6-12 Months After New Generation Drug Eluting Stent Implantation
|
Phase 4 | |
Recruiting |
NCT01994148 -
Application of Laparoscopy in Gastrointestinal Injury
|
N/A | |
Recruiting |
NCT05951517 -
Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura
|
N/A | |
Enrolling by invitation |
NCT05051358 -
Therapeutic Endoscopic Ultrasound for Gastrointestinal Disorders: A Multicenter Registry Study
|